High Rates of Death and Hospitalization Follow Bone Fracture Among Hemodialysis Patients
Overview
Authors
Affiliations
Altered bone structure and function contribute to the high rates of fractures in dialysis patients compared to the general population. Fracture events may increase the risk of subsequent adverse clinical outcomes. Here we assessed the incidence of post-fracture morbidity and mortality in an international cohort of 34,579 in-center hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). We estimated country-specific rates of fractures requiring a hospital admission and associated length of stay in the hospital. Incidence rates of death and of a composite event of death/rehospitalization were estimated for 1 year after fracture. Overall, 3% of participants experienced a fracture. Fracture incidence varied across countries, from 12 events/1000 patient-years (PY) in Japan to 45/1000 PY in Belgium. In all countries, fracture rates were higher in the hemodialysis group compared to those reported for the general population. Median length of stay ranged from 7 to 37 days in the United States and Japan, respectively. In most countries, postfracture mortality rates exceeded 500/1000 PY and death/rehospitalization rates exceeded 1500/1000 PY. Fracture patients had higher unadjusted rates of death (3.7-fold) and death/rehospitalization (4.0-fold) compared to the overall DOPPS population. Mortality and hospitalization rates were highest in the first month after the fracture and declined thereafter. Thus, the high frequency of fractures and increased adverse outcomes following a fracture pose a significant health burden for dialysis patients. Fracture prevention strategies should be identified and applied broadly in nephrology practices.
Icatoiu E, Vladulescu-Trandafir A, Groseanu L, Berghea F, Cobilinschi C, Potcovaru C Diagnostics (Basel). 2025; 15(5).
PMID: 40075802 PMC: 11898608. DOI: 10.3390/diagnostics15050555.
Matias P, Avila G, Domingos D, Gil C, Ferreira A Clin Kidney J. 2025; 18(1):sfae381.
PMID: 40008355 PMC: 11852323. DOI: 10.1093/ckj/sfae381.
Chronic Kidney Disease and Osteoarthritis: Current Understanding and Future Research Directions.
Yang R, Chan D, Chung Y, Liu S Int J Mol Sci. 2025; 26(4).
PMID: 40004032 PMC: 11854965. DOI: 10.3390/ijms26041567.
Takahashi R, Yabe H, Ishikawa H, Hibino T, Suzumura A, Yamada T J Nephrol. 2025; .
PMID: 39847209 DOI: 10.1007/s40620-024-02192-3.
The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease.
Aleksova J, Ebeling P, Elder G Nat Rev Endocrinol. 2025; .
PMID: 39820573 DOI: 10.1038/s41574-024-01083-8.